Assessment of FDA and EMA approved systemic oncology therapies and clinically meaningful improvements in quality of life

11 February 2021 - Are oncology therapies recently approved by the US FDA and the EMA associated with clinically meaningful improvements ...

Read more →

The estimation of health state utility values in rare diseases: overview of existing techniques

25 September 2020 - There are several techniques for estimating health state utility values, each of which presents pros and cons ...

Read more →

What is it going to be, TTO or SG? A direct test of the validity of health state valuation

12 August 2020 - It has been suggested that time trade-off yields more accurate health state valuations, because time trade-off ...

Read more →

A comparison of the EQ-5D-3L and EQ-5D-5L

12 May 2020 - Previous studies have found the EQ-5D-5L to have superior measurement properties but no study has compared ...

Read more →

Explaining health state utility assessment

17 March 2020 - Health state utilities are used to provide quantitative measures of how strongly a person values a certain ...

Read more →

Researchers wanted to study the public’s views of health-related quality of life

12 February 2020 - Applications close on Wednesday 4 March 2020 ...

Read more →

NICE to support new valuation study for England for EQ-5D-5L questionnaire

24 October 2019 - Study will measure public’s preference for different health states. ...

Read more →

The impact of moving from the EQ-5D-3L to the -5L in NICE technology appraisals

11 January 2019 - The EQ-5D instrument is NICE’s preferred measure of health-related quality of life in adults.  ...

Read more →

Evaluating progression-free survival as a surrogate outcome for health-related quality of life in oncology

1 October 2018 - Progression-free survival has become a commonly used outcome to assess the efficacy of new cancer drugs. However, ...

Read more →

Differentiation of health-related quality of life outcomes between five disease areas: results from an international survey of patients

25 September 2018 - Health-related quality of life data generated by generic, preference-based instruments are highly demanded in health policy decision ...

Read more →

Metastatic breast cancer: highly selective post-hoc analysis rather than complete publication of quality of life data

13 June 2018 - IQWiG employees criticise the publication practice of PALOMA-2 study authors. ...

Read more →

3L, 5L, What the L? A NICE conundrum

20 May 2018 - For many years, NICE has recommended use of the EQ-5D-3L and its value set for the UK.  ...

Read more →

What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews

27 April 2018 - Finch assessed the evidence on the validity and responsiveness of five commonly used preference-based instruments, the ...

Read more →

The “utility” in composite outcome measures

14 November 2017 - Measuring what is important to patients. ...

Read more →

Quality of life: an important element of treatment value

9 November 2017 - In the era of platinum-based chemotherapy, attempts to improve the quality of life of patients with advanced ...

Read more →